2 Of the 74 letters following on-site inspections, seven followed bioresearch monitoring (BIMO) inspections, 3 eight focused on human cell, tissue, or cellular products (HCTP), 4 two followed good laboratory practice (GLP) inspections, 5 nine were issued to pharmaceutical compounding firms, 6 and one was issued to a PET drug manufacturer
The identification of those at risk for NAFLD and NASH is imprecise (Box 1), and there is inadequate knowledge of the natural history, key pathogenic drivers and optimal in vitro and animal models to mimic the disease and test new agents
10.3389/fimmu.2023.1137822 [DOI] [PMC free article] [PubMed] [Google Scholar] 263.Wu, H
At the same time, previous studies have proposed the physiological and behavioral factors of weight regain [48] may better complement the relationship between weight loss and weight regain